This NPDA Annual Conference is a free hybrid event, offering the opportunity to attend either in person or online.
The 2026 theme focuses on health inequalities, early-stage Type 1 diabetes, Type 2 diabetes, and poverty proofing.
Royal National Hotel
38-51 Bedford Way
London
WC1H 0DG
United Kingdom
Overview
The NPDA collects information on the care and outcomes of children and young people with diabetes across England, Wales and Jersey. The audit supports paediatric diabetes units to monitor performance, share learning, and improve care quality and outcomes.
The NPDA Annual Conference is open to all professionals and stakeholders involved in paediatric diabetes care and research. This includes paediatric diabetes multidisciplinary teams (consultants, nurses, dietitians, psychologists and administrators), regional network leads, commissioners, data analysts, and representatives from patient organisations.
This event provides a great opportunity to explore the latest NPDA findings, share good practice, and hear from leading experts from the UK and internationally.
You can also view presentations and recordings from previous NPDA Annual Conferences to explore highlights from past events.
Programme
The programme below outlines the speakers and topics featured at this year’s NPDA Annual Conference. The event will be chaired by Dr Fiona Campbell, Consultant Paediatrician and Clinical Lead of the National CYP Diabetes Network.
| Time |
Programme Item |
| 09:30 - 10:00 |
Registration and Refreshments (in-person attendees) |
| 10:00 - 10:10 |
Chair's Welcome Chair |
| 10:10 - 10:30 |
NPDA Update 2024-25 Professor Justin Warner, NPDA Clincal Lead & Consultant Paediatric Endocrinologist, Cardiff and Vale University Health Board |
| 10:30 - 11:00 |
RCPCH&US - CYP Diabetes Communication Project Emma Sparrow, Head of CYP Engagement, Royal College of Paediatrics and Child Health Anita Sehdev, CYP Engagement, Royal College of Paediatrics and Child Health |
| 11:00 - 11:15 |
Ongoing inequalities 10 years on: experience from the NPDA Dr Ranuka Dias, Birmingham Children's Hospital, UK |
| 11:15 - 11:30 |
Inequalities in children and young people with poor glycaemic control (HbA1c > 75 mmol/mol (9.0%)) - findings from the NPDA for England and Wales Zhaonan Fang, NPDA Analyst, Royal College of Paediatrics and Child Health |
| 11:30 - 12:00 | Coffee Break |
| 12:00 - 12:30 |
Screening for pre-Type 1 diabetes, who, where and how should we do it? Dr Rachel Besser, Consultant Paediatrician, Oxford Children’s Hospital, Subtheme Lead for the Oxford NIHR Biomedical Research Centre |
| 12:30 – 13:00 |
Immunotherapy: beyond insulin for Type 1 diabetes, the past, present and future. Professor Colin Dayan, Professor of Clinical Diabetes & Metabolism, Cardiff University School of Medicine |
| 13:00 – 14:00 | Lunch |
| 14:00 – 14:30 |
Type 2 diabetes in youth: diagnostic and treatment challenges. Professor Sheela Magge, Director of the Division of Paediatric Endocrinology, |
| 14:30 – 15:00 |
Type 2: Lessons learnt from the NPDA spotlight audit. Dr Evelien Gevers, Consultant Paediatrician in Endocrinology and Diabetes, Barts Health NHS Trust, Royal London Hospital |
| 15:00 – 15:15 | Afternoon Break |
| 15:15 – 15:30 |
Higher odds of microvascular complications in T2D vs T1D, independent of HbA1c and BMI. Saira Pons-Perez: Audits Senior Analyst, Royal College of Paediatrics and Child Health |
| 15:45 – 16:00 |
Progress update and next steps for the NPDA Amani Krayem, NPDA Project Manager, Royal College of Paediatrics and Child Health |
| 16:00 |
Closing remarks and final reflections Chair |